Company Overview of MSI Methylation Sciences Inc.
MSI Methylation Sciences Inc. operates as a biotechnology company. It develops pharmaceuticals based on molecules. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in Burnaby, Canada.
4475 Wayburne Drive
Burnaby, BC V5G 4X4
Founded in 2007
Key Executives for MSI Methylation Sciences Inc.
MSI Methylation Sciences Inc. Key Developments
Similar Private Companies By Industry
|Whistler Medical Marijuana Company||Americas|
|Kaneq Bioscience Ltd.||Americas|
|King Pharmaceuticals Canada, Inc.||Americas|
|Bio-K Plus International Inc.||Americas|
|Apotex Pharmaceutical Holdings Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- New York, NY | PwCPosted: Aug 20
- Washington, DC | PwCPosted: Aug 20
- Portland, OR | InventivPosted: Apr 17
Sponsored Financial Commentaries
To contact MSI Methylation Sciences Inc., please visit www.methylationsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.